Literature DB >> 11026519

Assessment of iron status in cystic fibrosis patients.

B Keevil1, D Rowlands, I Burton, A K Webb.   

Abstract

We investigated the use of soluble transferrin receptor (sTfR), together with more traditional measurements such as iron, transferrin and ferritin, to assess iron status in 70 adult cystic fibrosis patients. sTfR concentration was measured using particle-enhanced immunonephelometry. We found that 69% of subjects as determined by transferrin saturation had iron deficiency, but only 29% as determined by sTfR and 11% as determined by ferritin. We found a significant correlation between C-reactive protein (CRP) and both ferritin (r = 0.38, P = 0.0001) and transferrin saturation (r = -0.54, P < 0.0001). In addition, because the CRP concentration was elevated in 64% of subjects, we feel that the transferrin saturation was overestimating, and the ferritin underestimating, iron deficiency in these patients. The sTfR concentration, on the other hand, is unaffected by the acute-phase response and was therefore thought to be the most useful test for detecting iron deficiency in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11026519     DOI: 10.1258/0004563001899708

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  10 in total

1.  Intussusception and metastatic colon cancer in an adult with cystic fibrosis.

Authors:  Francis J Gilchrist; Andrew M Jones; Rowland J Bright-Thomas
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

2.  Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

Authors:  Alex H Gifford; Diana M Alexandru; Zhigang Li; Dana B Dorman; Lisa A Moulton; Katherine E Price; Thomas H Hampton; Mitchell L Sogin; Jonathan B Zuckerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  J Cyst Fibros       Date:  2013-12-13       Impact factor: 5.482

Review 3.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

4.  The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost.

Authors:  J Jason; L K Archibald; O C Nwanyanwu; M Bell; R J Jensen; E Gunter; I Buchanan; J Larned; P N Kazembe; H Dobbie; W R Jarvis
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

5.  What is hepcidin telling us about the natural history of cystic fibrosis?

Authors:  A H Gifford
Journal:  J Cyst Fibros       Date:  2014-04-30       Impact factor: 5.482

6.  Are annual blood tests in preschool cystic fibrosis patients worthwhile?

Authors:  A Jaffé; R Buchdahl; A Bush; I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

7.  Iron homeostasis during cystic fibrosis pulmonary exacerbation.

Authors:  Alex H Gifford; Lisa A Moulton; Dana B Dorman; Gordana Olbina; Mark Westerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  Clin Transl Sci       Date:  2012-06-01       Impact factor: 4.689

8.  Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.

Authors:  Alex H Gifford; Julie L Sanville; Meghana Sathe; Sonya L Heltshe; Christopher H Goss
Journal:  Pediatr Pulmonol       Date:  2021-04-26

Review 9.  Update on the management of vitamins and minerals in cystic fibrosis.

Authors:  Senthilkumar Sankararaman; Sara J Hendrix; Terri Schindler
Journal:  Nutr Clin Pract       Date:  2022-08-23       Impact factor: 3.204

10.  Iron Deficiency in Cystic Fibrosis: A Cross-Sectional Single-Centre Study in a Referral Adult Centre.

Authors:  Hervé Lobbes; Stéphane Durupt; Sabine Mainbourg; Bruno Pereira; Raphaele Nove-Josserand; Isabelle Durieu; Quitterie Reynaud
Journal:  Nutrients       Date:  2022-02-05       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.